Mark Jeffrey Delong - Net Worth and Insider Trading

Mark Jeffrey Delong Net Worth

The estimated net worth of Mark Jeffrey Delong is at least $2 Million dollars as of 2024-11-06. Mark Jeffrey Delong is the Chief Business & Strat Officer of Apellis Pharmaceuticals Inc and owns about 54,693 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $2 Million. Details can be seen in Mark Jeffrey Delong's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Jeffrey Delong has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark Jeffrey Delong

To

Mark Jeffrey Delong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Jeffrey Delong owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .

Click here to see the complete history of Mark Jeffrey Delong’s form 4 insider trades.

Insider Ownership Summary of Mark Jeffrey Delong

Ticker Comapny Transaction Date Type of Owner
APLS Apellis Pharmaceuticals Inc 2024-03-18 Senior Vice President

Mark Jeffrey Delong Latest Holdings Summary

Mark Jeffrey Delong currently owns a total of 1 stock. Mark Jeffrey Delong owns 54,693 shares of Apellis Pharmaceuticals Inc (APLS) as of March 18, 2024, with a value of $2 Million.

Latest Holdings of Mark Jeffrey Delong

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APLS Apellis Pharmaceuticals Inc 2024-03-18 54,693 28.08 1,535,506

Holding Weightings of Mark Jeffrey Delong


Mark Jeffrey Delong Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Jeffrey Delong has made a total of 17 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 9,913 shares on March 18, 2024, which brought Mark Jeffrey Delong around $564,050.

Insider Trading History of Mark Jeffrey Delong

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Jeffrey Delong Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Jeffrey Delong Ownership Network

Ownership Network List of Mark Jeffrey Delong

No Data

Ownership Network Relation of Mark Jeffrey Delong

Insider Network Chart

Mark Jeffrey Delong Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Mark Jeffrey Delong is the Senior Vice President of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Mark Jeffrey Delong made 6 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 14,023. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,275,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,275,451 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

Mark Jeffrey Delong Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Jeffrey Delong. You might contact Mark Jeffrey Delong via mailing address: 100 5th Avenue, 3rd Floor, Waltham Ma 02451.